Yoga as a lifestyle polypill

7
881 J. Preventive Cardiology Vol. 5 No. 3 Feb 2016 Abstract Yoga is a holistic lifestyle and includes healthy diet (sattvic diet), physical exercise, stress management, and tobacco control, and, hence, it could be called as a lifestyle polypill. Yoga is becoming increasingly popular throughout the world because of its health benefit. Even the United Nations has realized its importance and has declared June 21 as the International Day of Yoga. Many studies suggest that the yoga lifestyle may be helpful in controlling risk factors for coronary heart disease life hypertension, type II diabetes mellitus, dyslipidemia, inflammation, oxidative and psychosocial stress, obesity, and smoking. A recent scientific statement of the American Heart Association has concluded that meditation could be considered as an alternative approach to lower blood pressure in all individual with blood pressure levels more than 120/80 mmHg. Yoga has also been shown to be beneficial in the secondary prevention of coronary heart disease, cardiac rehabilitation, cardiac arrhythmias, and congestive heart failure. Yoga may even regress early and advanced atherosclerosis. However, there are several limitations of the reported studies, and methodologies are generally poor. Large multicenter, well-planned randomized trials are Complementary and Alternative Medicine Article Yoga as a lifestyle polypill Dr. Subhash Manchanda, MD (Medicine), DM (Cardiology) Senior Consultant Cardiologist, Sir Ganga Ram Hospital, New Delhi, India needed to confirm these findings. However, as yoga is a cost-effective, simple holistic lifestyle without any side effects, it could be recommended for primary and secondary prevention of cardiovascular disease and it can play a primary and complimentary role in this regard. Key Words • Meditation • Risk factors • Regression of atherosclerosis • Cardiac prevention • Yoga • Lifestyle Introduction The word “Yoga” comes from a Sanskrit word “yug,” meaning to join together. It connotes going from lower consciousness to the higher. Originating in India 5000 1 years earlier, today, the practice of yoga is becoming 2,3 increasingly popular throughout the world. Even the United Nations has recognized its importance and declared June 21 as the “International Day of Yoga.” Received: 07-11-2015; Revised: 16-01-2016; Accepted: 15-02-2016 Disclosures: This article has not received any funding and has no vested commercial interest Acknowledgments: None

Transcript of Yoga as a lifestyle polypill

Page 1: Yoga as a lifestyle polypill

Suggestions for next steps include the development of standard referral forms for use at the time of patients’ hospital discharge and improved communication among tertiary care, community care, and cardiac rehabilitation providers to facilitate access to cardiac rehabilitation

11programs.

Yoga and cardiac rehabilitaion

Cardiac rehabilitation has been shown to be beneficial in the recovery process after myocardial infarction. Among its component interventions, evidence suggests that exercise may have a stronger effect on mortality, while psychosocial interventions act more on quality of life measures.

Although exercise-based cardiac rehabilitation has found to be extremely useful, there are limitations for developing countries like India, especially the cost and lack of manpower. Therefore, there is a need for an alternative simple and cost-effective technique. Yoga may be such an alternative technique.

Yoga practice leads to similar outcomes as cardiac rehabilitation (improved physical fitness, stress reduction, and lifestyle change). Yoga has contributed to the general well-being, decreased physiological arousal, better sleep, and appetite. Therefore, yoga could provide a useful framework to develop an economical cardiac

12rehabilitation program.

Accordingly, a large Indo-UK study has been initiated to study the effectiveness of a yoga-based cardiac rehabilitation program (Yoga-CaRe), compared with the enhanced standard care group, in patients following acute myocardial infarction on cardiac morbidity, mortality and quality of life.

References

1. World Health Organization. Needs and action priorities in cardiac rehabilitation and secondary prevention in patients with coronary heart disease. Geneva: WHO Regional Office for Europe; 1993.

2. Thomas RJ, King M, Lui K, et al. AACVPR/ ACCF/AHA 2010 update: Performance measures on cardiac rehabilitation for referral to cardiac rehabilitation/secondary prevention services: A report of the American Association of Cardiovascular and Pulmonary Rehabilitation and the American College of Cardiology Foundation/American Heart Association task force on performance measures (writing committee to develop clinical performance measures for cardiac rehabilitation). Circulation. 2010;122:1342–50.

3. Kwan G, Balady GJ. Cardiac rehabilitation 2012: Advancing the field through emerging science. Circulation. 2012; 125(7): e369–73.

4. Perk J, De Backer G, Gohlke H, et al. European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur. Heart J. 2012;33:1635–701.

5. Madan K, Babu AS, Contractor A, et al. Cardiac rehabilitation in India. Prog Cardiovasc Dis. 2014;56:543–50.

6. Chauhan U, Baker D, Lester H, et al. Exploring uptake of cardiac rehabilitation in a minority ethnic population in England: A qualitative study. Eur J Cardiovasc Nurs. 2010;9:68–74.

7. Cooper AF, Jackson G, Weinman J, et al. Factors associated with cardiac rehabilitation attendance: A systematic review of the literature. Clin Rehabil. 2002;16:541–52.

8. Pasquali SK, Alexander KP, Peterson ED. Cardiac rehabilitation in the elderly. Am Heart J 2001;142:748–55.

9. Ades PA, Waldmann ML, McCann W, et al. Predictors of cardiac rehabilitation in older coronary patients. Arch Intern Med. 1992;12:1033–5.

10. Oldridge NB, Rogowski B, Gottlieb M. Use of outpatient cardiac rehabilitation services: Factors associated with attendance. J Cardiopulm Rebabil. 1992;12:25–31.

11. Cortés O, Arthur HM. Determinants of referral to cardiac rehabilitation programs in patients with coronary artery disease: A systematic review. Am Heart J. 2006;151:249–56.

12. Manchanda S, Madan K. Yoga and meditation in cardiovascular disease. Clin Res Cardiol. 2014;103:675–80.

Address for correspondence:

Dr. Kushal MadanEmail ID: [email protected]

881880 J. Preventive Cardiology Vol. 5 No. 3 Feb 2016J. Preventive Cardiology Vol. 5 No. 3 Feb 2016

Abstract

Yoga is a holistic lifestyle and includes healthy diet (sattvic diet), physical exercise, stress management, and tobacco control, and, hence, it could be called as a lifestyle polypill. Yoga is becoming increasingly popular throughout the world because of its health benefit. Even the United Nations has realized its importance and has declared June 21 as the International Day of Yoga. Many studies suggest that the yoga lifestyle may be helpful in controlling risk factors for coronary heart disease life hypertension, type II diabetes mellitus, dyslipidemia, inflammation, oxidative and psychosocial stress, obesity, and smoking. A recent scientific statement of the American Heart Association has concluded that meditation could be considered as an alternative approach to lower blood pressure in all individual with blood pressure levels more than 120/80 mmHg. Yoga has also been shown to be beneficial in the secondary prevention of coronary heart disease, cardiac rehabilitation, cardiac arrhythmias, and congestive heart failure. Yoga may even regress early and advanced atherosclerosis. However, there are several limitations of the reported studies, and methodologies are generally poor. Large multicenter, well-planned randomized trials are

Complementary and Alternative Medicine Article

Yoga as a lifestyle polypill

Dr. Subhash Manchanda, MD (Medicine), DM (Cardiology)

Senior Consultant Cardiologist, Sir Ganga Ram Hospital, New Delhi, India

needed to confirm these findings. However, as yoga is a cost-effective, simple holistic lifestyle w i thou t any s ide e f fec ts , i t cou ld be recommended for primary and secondary prevention of cardiovascular disease and it can play a primary and complimentary role in this regard.

Key Words

• Meditation

• Risk factors

• Regression of atherosclerosis

• Cardiac prevention

• Yoga

• Lifestyle

Introduction

The word “Yoga” comes from a Sanskrit word “yug,” meaning to join together. It connotes going from lower consciousness to the higher. Originating in India 5000

1years earlier, today, the practice of yoga is becoming 2,3increasingly popular throughout the world. Even the

United Nations has recognized its importance and declared June 21 as the “International Day of Yoga.”

Received: 07-11-2015; Revised: 16-01-2016; Accepted: 15-02-2016

Disclosures: This article has not received any funding and has no vested commercial interest

Acknowledgments: None

Madan K, et al

Page 2: Yoga as a lifestyle polypill

883882 J. Preventive Cardiology Vol. 5 No. 3 Feb 2016J. Preventive Cardiology Vol. 5 No. 3 Feb 2016

Manchanda S

Yoga is an integrated system of self-culture that aims at harmonious development of body and mind and covers all aspects of human life that lead to physical well-being, mental harmony culminatory into posture thinking, happiness, and peace. Yoga envisages health in totality on the principle of a healthy mind in a healthy body. Yoga is a universal practical discipline irrespective of culture, nationality, caste, creed, sex, age, and physical conditions. Though there are several types of yoga described in ancient literature, hatha yoga is most commonly practiced. Core components of hatha yoga include stretching exercises and postures (asanas), breath control (pranayama), and concentration and thinking techniques (meditation) designed to promote physical, mental, emotional, social, and spiritual well-being. Yoga is a holistic lifestyle that includes all components of healthy lifestyle such as low-fat, vegetarian diet (satvik diet); physical exercises; tobacco avoidance; and stress control, and, hence, may be described as a “lifestyle polypill.”

Beneficial effects of yoga lifestyle

Beneficial effects of yoga have been reported in multiple chronic conditions including depression, stress, anxiety, menopausal symptoms, arthritis, low back pain, cancer, allergies, asthma, acid peptic disease, irritable bowel syndrome, migraine, metabolic syndrome, diabetes

4–7mellitus (DM), cardiovascular disease (CVD), etc. Yoga appears to be especially beneficial in CVD prevention.

Yoga for control of risk factors

Hypertension

Numerous studies have been conducted to assess the role of yoga in the management of hypertension. In earlier uncontrolled studies, the use of shavasana (corpse posture, a type of yogic activity for relaxation) and transcendental meditation (TM) were reported to lower

8,9both systolic and diastolic blood pressure significantly. In a randomized trial, yoga was found to be equally effective as an antihypertensive therapy over a 11-week

1 0period. Another randomized controlled trial demonstrated that yoga and biofeedback were capable of producing long-term beneficial effects in the treatment

11of hypertension. A meta-analysis involving nine well-controlled randomized trials showed that, compared with control, TM was associated with a modest decrease of systolic blood pressure of 4.7 mmHg and diastolic

12blood pressure of 3.2 mmHg. Recently, several controlled studies and meta-analysis have reported about the immediate and long-term effects of yoga practices in

13–19pre-hypertension and mildly hypertensives. Although the results are mixed, majority of the trials show a modest decrease in blood pressure. However, most of the studies have low methodological quality, and, hence, large randomized well-controlled studies are needed for defining the role of yoga in hypertension. A scientific statement of the American Heart Association has recently concluded that TM and biofeedback approaches show a modest effect in reducing blood pressure (Class IIb, Level of Evidence: B), and, hence, has suggested that it is reasonable for all individuals with blood pressure levels >120/80 mmHg to consider alternative approaches like TM as adjunct methods to lower blood

20pressure when clinically appropriate.

DM and metabolic syndrome

Yoga has been shown to be a simple, cost-effective therapeutic modality as an adjunct for type II DM

21–24patients. Similarly, regular practice of yoga has been shown to improve several components of metabolic syndrome such as insulin resistance, body mass index, waist circumference, dyslipidemia, blood pressure, and

25–28HbA1C. Yoga has also been reported to regress early atherosclerosis in metabolic syndrome, as assessed by

29carotid intimal medial thickness.

Lipid profile

Several randomized controlled trials have demonstrated significant improvement in lipid profiles by practicing yoga for 6 weeks to 2 years in healthy subjects and in patients with hypertension, DM, and coronary heart

30–34disease. A recent randomized trial has demonstrated a significant decrease in total cholesterol, triglycerdies, and low-density lipoproteins cholesterol (LDL-C), and improvement in high-density lipoproteins (HDL)

35cholesterol in diabetic patients with dyslipidemia. A meta-analysis of 30 randomized control trials in 751 subjects demonstrated that LDL-C decreased by 12

36mg/dL as compared with controls. However, many studies have utilized diet control, health education, and other therapies in addition to yoga. Hence, results have to be interpreted cautiously. It may be concluded that yoga may compliment the current drug regimen to lower lipids, and thereby further decrease the risk of CVD.

Tobacco

A few randomized and non-randomized studies suggest that different types of yoga intervention alone or with behavior therapy may be able to enhance quitting

37,38smoking rates. A recent randomized controlled trial suggested that a brief training of mindfulness meditation reduced smoking by 60% and also curbed craving in

smokers. These changes were probably related to improved self-control, as demonstrated by increased activity in the anterior cingulated and pre-frontal cortex

39in functional MRI. Two meta-analysis have also suggested that yoga intervention holds promise as an efficacious complimentary therapy for smoking

40,41cessation. However, the follow up has been short ranging from 8 weeks to 6 months.

Inflammation, oxidative stress, and procoagulant status

Two small uncontrolled trials have suggested that yoga practices for 12–16 weeks result in a significant decline

42,43in fibrinogen and increase in fibrinolytic activity. A few other small studies suggest that yoga may reduce oxidative stress in both healthy population and chronic

44–47insulin resistance-related disorders. Sarvottam et al. demonstrated that after 10 days of yoga intervention in 51 obese individuals, a significant reduction in plasma IL-6 and an increase in plasma adiponectin was observed, suggesting that even short-term yoga-based program may reduce the risk of CVD, as indicated by a

48decrease in inflammatory markers. However, this is a non-randomized study, and diet and exercises have also been used.

Psychosocial stress

Psychosocial stress is a significant risk factor for hypertension, stroke, myocardial infarction, insulin

49resistance, and cardiovascular mortality. Recently, the American Heart Association has suggested that depression should be considered as a major risk factor similarly to smoking, hypertension, diabetes, and

50obesity. There is experimental evidence to suggest that yoga can lead to improvement in cardiovascular response to stress and cardiovascular recovery from

51stress. Several studies also suggest that stress can be reduced significantly with regular practice of yoga and

4,52–54meditation. One study suggests that yoga may be as

55useful as drugs to control depression.

Obesity

Several randomized controlled trials have demonstrated an improvement in body weight and/or composition by

30,56–58yoga-based programs relative to control. These studies have been performed in healthy individuals and those with hypertension and other CVD risk factors, type II DM, and coronary heart disease. Yoga was associated with a 1.5 to 13.5% decrease in body weight. Central obesity in metabolic syndrome has also been shown to be

29decreased by regular practice of yoga.

Regression of atherosclerosis

Both early and advanced atherosclerosis has been shown to be significantly reduced by regular practice of yoga for 9 months to 1 year. Fields et al., utilizing TM, and Manchanda et al., utilizing yoga practices, have demonst ra ted tha t 9–12 months prac t ice of yoga/meditation significantly reduced carotid intima-media thickness in patients with hypertension and

29,59metabolic syndrome. Four small controlled studies utilizing coronary angiography in advanced coronary heart disease showed that regular practice of yoga for 1–5 years along with the use of low-fat vegetarian diet cause retardation or regression of coronary stenosis as

56,60–62compared with the usual care group. In addition, the lipid profiles, body weight, mental stress, myocardial ischemia, and need for interventional procedures were also significantly reduced as compared with controls.

Cardiac rehabilitation

Yoga practices have been shown to contribute to the general well-being, decreased physiological arousal, better sleep, better appetite, and decreased psychosocial

63–65stress? Therefore, yoga could provide a useful framework to develop an economical cardiac rehabilitation program. In a small randomized control trial, Tulpule et al. reported that yoga-based cardiac rehabilitation in 102 post-MI patients was associated with decreased mortality and more patients resuming

66work within 6 months. Recently, a study utilizing yoga-based cardiac rehabilitation after coronary artery bypass surgery demonstrated a significant decrease in perceived

67stress, anxiety, depression, and negative effects. The left ventricular ejection fraction was also reported to be improved with reduction in blood glucose and decrease in LDL and increase in HDL. Silberman et al., in a yoga-based intensive cardiac rehabilitation program in 2,974 individuals from 24 diverse sites, also concluded that yoga-based cardiac rehabilitation program was feasible and sustainable for most patients and was associated with numerous subjective and objective improvements in

68health outcomes. Recently, a randomized control trial of TM has reported that there was a 48% risk reduction in primary end points (composite of all-cause mortality, myocardial infarction, and stroke) over a period of 5.5

69years.

Arrhythmias and heart failure

A few studies have demonstrated that yoga may be useful in control of premature ventricular ectopics and may also decrease the atrial fibrillation burden in patients with

70,71paroxysmal atrial fibrillation. Yoga has also been reported to be useful in heart failure patients by improving peak oxygen consumption, quality of life, and

Yoga as a lifestyle polypill

Page 3: Yoga as a lifestyle polypill

883882 J. Preventive Cardiology Vol. 5 No. 3 Feb 2016J. Preventive Cardiology Vol. 5 No. 3 Feb 2016

Manchanda S

Yoga is an integrated system of self-culture that aims at harmonious development of body and mind and covers all aspects of human life that lead to physical well-being, mental harmony culminatory into posture thinking, happiness, and peace. Yoga envisages health in totality on the principle of a healthy mind in a healthy body. Yoga is a universal practical discipline irrespective of culture, nationality, caste, creed, sex, age, and physical conditions. Though there are several types of yoga described in ancient literature, hatha yoga is most commonly practiced. Core components of hatha yoga include stretching exercises and postures (asanas), breath control (pranayama), and concentration and thinking techniques (meditation) designed to promote physical, mental, emotional, social, and spiritual well-being. Yoga is a holistic lifestyle that includes all components of healthy lifestyle such as low-fat, vegetarian diet (satvik diet); physical exercises; tobacco avoidance; and stress control, and, hence, may be described as a “lifestyle polypill.”

Beneficial effects of yoga lifestyle

Beneficial effects of yoga have been reported in multiple chronic conditions including depression, stress, anxiety, menopausal symptoms, arthritis, low back pain, cancer, allergies, asthma, acid peptic disease, irritable bowel syndrome, migraine, metabolic syndrome, diabetes

4–7mellitus (DM), cardiovascular disease (CVD), etc. Yoga appears to be especially beneficial in CVD prevention.

Yoga for control of risk factors

Hypertension

Numerous studies have been conducted to assess the role of yoga in the management of hypertension. In earlier uncontrolled studies, the use of shavasana (corpse posture, a type of yogic activity for relaxation) and transcendental meditation (TM) were reported to lower

8,9both systolic and diastolic blood pressure significantly. In a randomized trial, yoga was found to be equally effective as an antihypertensive therapy over a 11-week

1 0period. Another randomized controlled trial demonstrated that yoga and biofeedback were capable of producing long-term beneficial effects in the treatment

11of hypertension. A meta-analysis involving nine well-controlled randomized trials showed that, compared with control, TM was associated with a modest decrease of systolic blood pressure of 4.7 mmHg and diastolic

12blood pressure of 3.2 mmHg. Recently, several controlled studies and meta-analysis have reported about the immediate and long-term effects of yoga practices in

13–19pre-hypertension and mildly hypertensives. Although the results are mixed, majority of the trials show a modest decrease in blood pressure. However, most of the studies have low methodological quality, and, hence, large randomized well-controlled studies are needed for defining the role of yoga in hypertension. A scientific statement of the American Heart Association has recently concluded that TM and biofeedback approaches show a modest effect in reducing blood pressure (Class IIb, Level of Evidence: B), and, hence, has suggested that it is reasonable for all individuals with blood pressure levels >120/80 mmHg to consider alternative approaches like TM as adjunct methods to lower blood

20pressure when clinically appropriate.

DM and metabolic syndrome

Yoga has been shown to be a simple, cost-effective therapeutic modality as an adjunct for type II DM

21–24patients. Similarly, regular practice of yoga has been shown to improve several components of metabolic syndrome such as insulin resistance, body mass index, waist circumference, dyslipidemia, blood pressure, and

25–28HbA1C. Yoga has also been reported to regress early atherosclerosis in metabolic syndrome, as assessed by

29carotid intimal medial thickness.

Lipid profile

Several randomized controlled trials have demonstrated significant improvement in lipid profiles by practicing yoga for 6 weeks to 2 years in healthy subjects and in patients with hypertension, DM, and coronary heart

30–34disease. A recent randomized trial has demonstrated a significant decrease in total cholesterol, triglycerdies, and low-density lipoproteins cholesterol (LDL-C), and improvement in high-density lipoproteins (HDL)

35cholesterol in diabetic patients with dyslipidemia. A meta-analysis of 30 randomized control trials in 751 subjects demonstrated that LDL-C decreased by 12

36mg/dL as compared with controls. However, many studies have utilized diet control, health education, and other therapies in addition to yoga. Hence, results have to be interpreted cautiously. It may be concluded that yoga may compliment the current drug regimen to lower lipids, and thereby further decrease the risk of CVD.

Tobacco

A few randomized and non-randomized studies suggest that different types of yoga intervention alone or with behavior therapy may be able to enhance quitting

37,38smoking rates. A recent randomized controlled trial suggested that a brief training of mindfulness meditation reduced smoking by 60% and also curbed craving in

smokers. These changes were probably related to improved self-control, as demonstrated by increased activity in the anterior cingulated and pre-frontal cortex

39in functional MRI. Two meta-analysis have also suggested that yoga intervention holds promise as an efficacious complimentary therapy for smoking

40,41cessation. However, the follow up has been short ranging from 8 weeks to 6 months.

Inflammation, oxidative stress, and procoagulant status

Two small uncontrolled trials have suggested that yoga practices for 12–16 weeks result in a significant decline

42,43in fibrinogen and increase in fibrinolytic activity. A few other small studies suggest that yoga may reduce oxidative stress in both healthy population and chronic

44–47insulin resistance-related disorders. Sarvottam et al. demonstrated that after 10 days of yoga intervention in 51 obese individuals, a significant reduction in plasma IL-6 and an increase in plasma adiponectin was observed, suggesting that even short-term yoga-based program may reduce the risk of CVD, as indicated by a

48decrease in inflammatory markers. However, this is a non-randomized study, and diet and exercises have also been used.

Psychosocial stress

Psychosocial stress is a significant risk factor for hypertension, stroke, myocardial infarction, insulin

49resistance, and cardiovascular mortality. Recently, the American Heart Association has suggested that depression should be considered as a major risk factor similarly to smoking, hypertension, diabetes, and

50obesity. There is experimental evidence to suggest that yoga can lead to improvement in cardiovascular response to stress and cardiovascular recovery from

51stress. Several studies also suggest that stress can be reduced significantly with regular practice of yoga and

4,52–54meditation. One study suggests that yoga may be as

55useful as drugs to control depression.

Obesity

Several randomized controlled trials have demonstrated an improvement in body weight and/or composition by

30,56–58yoga-based programs relative to control. These studies have been performed in healthy individuals and those with hypertension and other CVD risk factors, type II DM, and coronary heart disease. Yoga was associated with a 1.5 to 13.5% decrease in body weight. Central obesity in metabolic syndrome has also been shown to be

29decreased by regular practice of yoga.

Regression of atherosclerosis

Both early and advanced atherosclerosis has been shown to be significantly reduced by regular practice of yoga for 9 months to 1 year. Fields et al., utilizing TM, and Manchanda et al., utilizing yoga practices, have demonst ra ted tha t 9–12 months prac t ice of yoga/meditation significantly reduced carotid intima-media thickness in patients with hypertension and

29,59metabolic syndrome. Four small controlled studies utilizing coronary angiography in advanced coronary heart disease showed that regular practice of yoga for 1–5 years along with the use of low-fat vegetarian diet cause retardation or regression of coronary stenosis as

56,60–62compared with the usual care group. In addition, the lipid profiles, body weight, mental stress, myocardial ischemia, and need for interventional procedures were also significantly reduced as compared with controls.

Cardiac rehabilitation

Yoga practices have been shown to contribute to the general well-being, decreased physiological arousal, better sleep, better appetite, and decreased psychosocial

63–65stress? Therefore, yoga could provide a useful framework to develop an economical cardiac rehabilitation program. In a small randomized control trial, Tulpule et al. reported that yoga-based cardiac rehabilitation in 102 post-MI patients was associated with decreased mortality and more patients resuming

66work within 6 months. Recently, a study utilizing yoga-based cardiac rehabilitation after coronary artery bypass surgery demonstrated a significant decrease in perceived

67stress, anxiety, depression, and negative effects. The left ventricular ejection fraction was also reported to be improved with reduction in blood glucose and decrease in LDL and increase in HDL. Silberman et al., in a yoga-based intensive cardiac rehabilitation program in 2,974 individuals from 24 diverse sites, also concluded that yoga-based cardiac rehabilitation program was feasible and sustainable for most patients and was associated with numerous subjective and objective improvements in

68health outcomes. Recently, a randomized control trial of TM has reported that there was a 48% risk reduction in primary end points (composite of all-cause mortality, myocardial infarction, and stroke) over a period of 5.5

69years.

Arrhythmias and heart failure

A few studies have demonstrated that yoga may be useful in control of premature ventricular ectopics and may also decrease the atrial fibrillation burden in patients with

70,71paroxysmal atrial fibrillation. Yoga has also been reported to be useful in heart failure patients by improving peak oxygen consumption, quality of life, and

Yoga as a lifestyle polypill

Page 4: Yoga as a lifestyle polypill

885884 J. Preventive Cardiology Vol. 5 No. 3 Feb 2016J. Preventive Cardiology Vol. 5 No. 3 Feb 2016

72left ventricular ejection fraction; however, long-term studies are lacking.

Possible mechanism

Although the exact mechanisms underlying the potential beneficial effect of yoga on CV system are not fully understood, several postulations have been put forth.

73Streeter et al. have recently proposed a theory to explain the benefits of yoga in diverse, frequently comorbid medical conditions based on the concept that yoga reduces allostatic load in stress response systems so that optimal homeostasis is restored. They hypothesized that stress produces an:

• Imbalance of the autonomic nervous system with decreased parasympathet ic and increased sympathetic activity

• Under activity of the gamma amino butyric acid (GABA) sys t em, t he p r imary i nh ib i t o ry neurotransmitter system and

• Increased allostatic load

They further postulated that yoga-based practices correct under-activity of the parasympathetic nervous system and GABA systems, in part, through stimulation of vagus nerves, the main peripheral pathway of the parasympathetic nervous system, and reduce the

27allostatic load. Innes et al., in an exhaustive review, had earlier postulated two interconnected pathways by which yoga reduces the risk of CVDs through the mechanisms of parasympathetic activation coupled with decreased r e a c t i v i t y o f s y m p a t h o a d r e n a l s y s t e m a n d hypothalamic–pituitary–adrenal (HPA) axis (Figure 1). Their review of numerous studies suggested that yoga promotes a reduction of sympathetic activation, enhances cardiovagal function, and brings a shift in the autonomic nervous system balance from primarily sympathetic to parasympathetic, as shown by significant reduction in heart and respiratory rate, cortisol concentration, catecholamine levels, rennin activity, skin conductance, and cardiovascular response to stress as well as significant increases in heart rate variability (HRV) and baroreflex sensitivity. Low HRV and baroreflex sensitivity reflect impaired cardiovagal adaptability and suggest insufficient parasympathetic tone. These alterations are, in turn, strong independent predictors of cardiovascular morbidity and mortality. In contrast, high HRV and baroreflex sensitivity are generally considered to indicate good cardiovagal adaptations and sympathovagal balance, permitting greater responsibility and sensitivity to changes in environmental demands. These alterations in neurohumoral activity confer a protective effect against

coronary heart disease, hypertension, arrhythmias, and heart failure. Moreover, patients with heart disease also suffer from several other psychiatric comorbidities such

74,75as depression and anxiety. Alternatively, depression and anxiety also increase the risk of ischemic heart

74disease and congestive heart failure. Multiple studies have demonstrated improvement in depression, anxiety,

52–55and mood with yoga therapy.

Figure 1: Psychophysiology of yoga in heart disease-possible mechanisms (modified from Innes et al., 2005)

Limitations of yoga studies

Although several published studies have demonstrated that yoga is useful in primary and secondary prevention of CVD, there are many limitations with respect to the reported studies. Most of the studies are single center, have smal l sample s i ze , have non-un i fo rm methodologies, and only a limited number of RCTs have evaluated the impact of yoga on CVD. Majority of studies have short follow up and outcome studies are lacking. Multicentric large studies using uniform methodologies with long-term outcomes are needed. However, even with the present evidence and considering that yoga is a simple cost-effective technique with no side effects, yoga could be recommended alongside convention medical care for prevention of CVD and improving outcomes for those with CVD.

Conclusion

Yoga is a holistic lifestyle consisting of healthy diet, exercise, stress management, and tobacco control, and, hence, could be termed as a lifestyle polypill. Many

­ Insulin sensitivity­Glucose toleranceImproved lipid profileImproved mood, sleepEnhanced psychological profile

YOGAPathway 1 Pathway 2

Vagalstimulation

­ Heart rate variability¯Baroreflex sensitivity¯Inflammatory cytokines¯Heart rate, blood pressure

¯Stress¯Symp[athetic system¯Activation of HPA axis

Improved coagulation¯Oxidative stress­Endothelial function

Reduced risk foratheroslerosis,hypertension,arrhythmias, heart failure

studies suggest that the yoga lifestyle may be helpful in controlling risk factors for coronary heart disease like hypertension, type II DM, dyslipidemia, inflammation, oxidative and psychosocial stress, obesity, and smoking. Yoga has also been shown to be beneficial in the secondary prevention of coronary heart disease, cardiac rehabilitation, cardiac arrhythmias, and congestive heart failure. Yoga may even regress early and advanced atherosclerosis. However, there are several limitations of the reported studies, and methodologies are generally poor. Large multicenter well-planned randomized trials are needed to confirm these findings. However, as yoga is a cost-effective, simple holistic lifestyle without any side effects, it could be recommended for primary and secondary prevention of CVD and it can play a primary

76,77and complimentary role in this regard.

References

1. Ananda S. The complete book of yoga: Harmony of body and mind, 1st edn. Delhi: Orient; 1981.

2. Meditation practices for Health. State of the Research (2007) prepared for agency for Healthcare Research and Quantity; US Department of Health and Human Services.

3. Mak JC, Faux S. Complementary and alternative medicine use by osteoporotic patients in Australia (CAMEO-A): A prospective study. J Altern Complement Med. 2010;16:579–84.

4. Raub J. Psychophysiologic effects of Hatha Yoga on musculoskeletal and cardiopulmonary function: A literature review. J Altern Complement Med. 2002;8:797–812.

5. Jayasinghe SR. Yoga in cardiac health (a review). Eur J Cardiovasc Prev Rehabil. 2004;11:369–75.

6. Büssing A, Michalsen A, Khalsa SB, et al. Effects of yoga on mental and physical health: A short summary of reviews. Evid Based Complement Alternat Med. 2012;2012:165410.

7. Manchanda SC, Madan K. Yoga and meditation in cardiovascular disease. Clin Res Cardiol. 2014;103:675–80.

8. Datey KK, Deshmukh SN, Dalvi CP, et al. "Shavasan": A yogic exercise in the management of hypertension. Angiology. 1969;20:325–33.

9. Benson H, Rosner BA, Marzetta BR, et al. Decreased blood- pressure in pharmacologically treated hypertensive patients who regular ly e l ic i ted the re laxat ion response. Lancet . 1974;1:289–91.

10. Murugesan R, Govindarajulu N, Bera TK. Effect of selected yogic practices on the management of hypertension. Indian J Physiol Pharmacol. 2000;44:207–10.

11. Patel C. 12-month follow-up of yoga and bio-feedback in the management of hypertension. Lancet. 1975;1:62–4.

12. Anderson JW, Liu C, Kryscio RJ. Blood pressure response to transcendental meditation: A meta-analysis. Am J Hypertens. 2008;21:310–6.

13. Cramer H, Haller H, Lauche R, et al. A systematic review and meta-analysis of yoga for hypertension. Am J Hypertens. 2014;27:1146–51.

14. Cohen DL, Bloedon LT, Rothman RL, et al. Iyengar yoga versus enhanced usual care on blood pressure in patients with prehypertension to stage I hypertension: A randomized controlled trial. Evid Based Complement Alternat Med. 2011;2011:546428.

15. Hagins M, Rundle A, Consedine NS, et al. A randomized controlled trial comparing the effects of yoga with an active control on ambulatory blood pressure in individuals with prehypertension and stage 1 hypertension. J Clin Hypertens (Greenwich). 2014;16:54–62.

16. Wang J, Xiong X, Liu W. Yoga for essential hypertension: a systematic review. PLoS One. 2013;8:e76357.

17. Tyagi A, Cohen M. Yoga and hypertension: A systematic review. Altern Ther Health Med. 2014;20:32–59.

18. Posadzki P, Cramer H, Kuzdzal A, et al. Yoga for hypertension: A systematic review of randomized clinical trials. Complement Ther Med. 2014;22:511–22.

19. Chung SC, Brooks MM, Rai M, et al. Effect of Sahaja yoga meditation on quality of life, anxiety, and blood pressure control. J Altern Complement Med. 2012;18:589–96.

20. Brook RD, Appel LJ, Rubenfire M, et al. American Heart Association Professional Education Committee of the Council for High Blood Pressure Research, Council on Cardiovascular and Stroke Nursing, Council on Epidemiology and Prevention, and Council on Nutrition, Physical Activity. Beyond medications and diet: Alternative approaches to lowering blood pressure: A scientific statement from the American Heart Association. Hypertension. 2013;61:1360–83.

21. Jain S, Uppal A, Bhatnagar S, et al. A study of response pattern of non-insulin dependent diabetics to yoga therapy. Diabetes Res Clin Pract. 1993;19:69–74.

22. Singh S, Malhotra V, Singh KP, et al. Role of yoga in modifying certain cardiovascular functions in type 2 diabetic patients. J Assoc Phys India. 2004;52:203–6.

23. Malhotra V, Singh S, Tandon OP, et al. The beneficial effects of yoga in diabetes. Nepal Med Coll J. 2005;7:145–7.

24. Kosuri M, Sridhar GR. Yoga practice in diabetes improves physical and psychological outcomes. Metab Syndr Relat Disord. 2009;7:515–7.

25. Khatri D, Mathur KC, Gahlot S, et al. Effects of yoga and meditation on clinical and biochemical parameters of metabolic syndrome. Diabetes Res Clin Pract. 2007;78:e9–e10.

26. Cohen BE, Chang AA, Grady D, et al. Restorative yoga in adults with metabolic syndrome: a randomized, controlled pilot trial. Metab Syndr Relat Disord. 2008;6:223–9.

27. Innes KE, Bourguignon C, Taylor AG. Risk indices associated with the insulin resistance syndrome, cardiovascular disease, and possible protection with yoga: a systematic review. J Am Board Fam Pract. 2005;18:491–519.

28. Paul-Labrador M, Polk D, Dwyer JH, et al. Effects of a randomized controlled trial of transcendental meditation on components of the metabolic syndrome in subjects with coronary heart disease. Arch Intern Med. 2006;166:1218–24.

29. Manchanda SC, Mehrotra UC, Makhija A, et al. Reversal of early atherosclerosis in metabolic syndrome by yoga: A randomized controlled trial. J Yoga Phys Ther. 2013;3:132.

Manchanda S Yoga as a lifestyle polypill

Page 5: Yoga as a lifestyle polypill

885884 J. Preventive Cardiology Vol. 5 No. 3 Feb 2016J. Preventive Cardiology Vol. 5 No. 3 Feb 2016

72left ventricular ejection fraction; however, long-term studies are lacking.

Possible mechanism

Although the exact mechanisms underlying the potential beneficial effect of yoga on CV system are not fully understood, several postulations have been put forth.

73Streeter et al. have recently proposed a theory to explain the benefits of yoga in diverse, frequently comorbid medical conditions based on the concept that yoga reduces allostatic load in stress response systems so that optimal homeostasis is restored. They hypothesized that stress produces an:

• Imbalance of the autonomic nervous system with decreased parasympathet ic and increased sympathetic activity

• Under activity of the gamma amino butyric acid (GABA) sys t em, t he p r imary i nh ib i t o ry neurotransmitter system and

• Increased allostatic load

They further postulated that yoga-based practices correct under-activity of the parasympathetic nervous system and GABA systems, in part, through stimulation of vagus nerves, the main peripheral pathway of the parasympathetic nervous system, and reduce the

27allostatic load. Innes et al., in an exhaustive review, had earlier postulated two interconnected pathways by which yoga reduces the risk of CVDs through the mechanisms of parasympathetic activation coupled with decreased r e a c t i v i t y o f s y m p a t h o a d r e n a l s y s t e m a n d hypothalamic–pituitary–adrenal (HPA) axis (Figure 1). Their review of numerous studies suggested that yoga promotes a reduction of sympathetic activation, enhances cardiovagal function, and brings a shift in the autonomic nervous system balance from primarily sympathetic to parasympathetic, as shown by significant reduction in heart and respiratory rate, cortisol concentration, catecholamine levels, rennin activity, skin conductance, and cardiovascular response to stress as well as significant increases in heart rate variability (HRV) and baroreflex sensitivity. Low HRV and baroreflex sensitivity reflect impaired cardiovagal adaptability and suggest insufficient parasympathetic tone. These alterations are, in turn, strong independent predictors of cardiovascular morbidity and mortality. In contrast, high HRV and baroreflex sensitivity are generally considered to indicate good cardiovagal adaptations and sympathovagal balance, permitting greater responsibility and sensitivity to changes in environmental demands. These alterations in neurohumoral activity confer a protective effect against

coronary heart disease, hypertension, arrhythmias, and heart failure. Moreover, patients with heart disease also suffer from several other psychiatric comorbidities such

74,75as depression and anxiety. Alternatively, depression and anxiety also increase the risk of ischemic heart

74disease and congestive heart failure. Multiple studies have demonstrated improvement in depression, anxiety,

52–55and mood with yoga therapy.

Figure 1: Psychophysiology of yoga in heart disease-possible mechanisms (modified from Innes et al., 2005)

Limitations of yoga studies

Although several published studies have demonstrated that yoga is useful in primary and secondary prevention of CVD, there are many limitations with respect to the reported studies. Most of the studies are single center, have smal l sample s i ze , have non-un i fo rm methodologies, and only a limited number of RCTs have evaluated the impact of yoga on CVD. Majority of studies have short follow up and outcome studies are lacking. Multicentric large studies using uniform methodologies with long-term outcomes are needed. However, even with the present evidence and considering that yoga is a simple cost-effective technique with no side effects, yoga could be recommended alongside convention medical care for prevention of CVD and improving outcomes for those with CVD.

Conclusion

Yoga is a holistic lifestyle consisting of healthy diet, exercise, stress management, and tobacco control, and, hence, could be termed as a lifestyle polypill. Many

­ Insulin sensitivity­Glucose toleranceImproved lipid profileImproved mood, sleepEnhanced psychological profile

YOGAPathway 1 Pathway 2

Vagalstimulation

­ Heart rate variability¯Baroreflex sensitivity¯Inflammatory cytokines¯Heart rate, blood pressure

¯Stress¯Symp[athetic system¯Activation of HPA axis

Improved coagulation¯Oxidative stress­Endothelial function

Reduced risk foratheroslerosis,hypertension,arrhythmias, heart failure

studies suggest that the yoga lifestyle may be helpful in controlling risk factors for coronary heart disease like hypertension, type II DM, dyslipidemia, inflammation, oxidative and psychosocial stress, obesity, and smoking. Yoga has also been shown to be beneficial in the secondary prevention of coronary heart disease, cardiac rehabilitation, cardiac arrhythmias, and congestive heart failure. Yoga may even regress early and advanced atherosclerosis. However, there are several limitations of the reported studies, and methodologies are generally poor. Large multicenter well-planned randomized trials are needed to confirm these findings. However, as yoga is a cost-effective, simple holistic lifestyle without any side effects, it could be recommended for primary and secondary prevention of CVD and it can play a primary

76,77and complimentary role in this regard.

References

1. Ananda S. The complete book of yoga: Harmony of body and mind, 1st edn. Delhi: Orient; 1981.

2. Meditation practices for Health. State of the Research (2007) prepared for agency for Healthcare Research and Quantity; US Department of Health and Human Services.

3. Mak JC, Faux S. Complementary and alternative medicine use by osteoporotic patients in Australia (CAMEO-A): A prospective study. J Altern Complement Med. 2010;16:579–84.

4. Raub J. Psychophysiologic effects of Hatha Yoga on musculoskeletal and cardiopulmonary function: A literature review. J Altern Complement Med. 2002;8:797–812.

5. Jayasinghe SR. Yoga in cardiac health (a review). Eur J Cardiovasc Prev Rehabil. 2004;11:369–75.

6. Büssing A, Michalsen A, Khalsa SB, et al. Effects of yoga on mental and physical health: A short summary of reviews. Evid Based Complement Alternat Med. 2012;2012:165410.

7. Manchanda SC, Madan K. Yoga and meditation in cardiovascular disease. Clin Res Cardiol. 2014;103:675–80.

8. Datey KK, Deshmukh SN, Dalvi CP, et al. "Shavasan": A yogic exercise in the management of hypertension. Angiology. 1969;20:325–33.

9. Benson H, Rosner BA, Marzetta BR, et al. Decreased blood- pressure in pharmacologically treated hypertensive patients who regular ly e l ic i ted the re laxat ion response. Lancet . 1974;1:289–91.

10. Murugesan R, Govindarajulu N, Bera TK. Effect of selected yogic practices on the management of hypertension. Indian J Physiol Pharmacol. 2000;44:207–10.

11. Patel C. 12-month follow-up of yoga and bio-feedback in the management of hypertension. Lancet. 1975;1:62–4.

12. Anderson JW, Liu C, Kryscio RJ. Blood pressure response to transcendental meditation: A meta-analysis. Am J Hypertens. 2008;21:310–6.

13. Cramer H, Haller H, Lauche R, et al. A systematic review and meta-analysis of yoga for hypertension. Am J Hypertens. 2014;27:1146–51.

14. Cohen DL, Bloedon LT, Rothman RL, et al. Iyengar yoga versus enhanced usual care on blood pressure in patients with prehypertension to stage I hypertension: A randomized controlled trial. Evid Based Complement Alternat Med. 2011;2011:546428.

15. Hagins M, Rundle A, Consedine NS, et al. A randomized controlled trial comparing the effects of yoga with an active control on ambulatory blood pressure in individuals with prehypertension and stage 1 hypertension. J Clin Hypertens (Greenwich). 2014;16:54–62.

16. Wang J, Xiong X, Liu W. Yoga for essential hypertension: a systematic review. PLoS One. 2013;8:e76357.

17. Tyagi A, Cohen M. Yoga and hypertension: A systematic review. Altern Ther Health Med. 2014;20:32–59.

18. Posadzki P, Cramer H, Kuzdzal A, et al. Yoga for hypertension: A systematic review of randomized clinical trials. Complement Ther Med. 2014;22:511–22.

19. Chung SC, Brooks MM, Rai M, et al. Effect of Sahaja yoga meditation on quality of life, anxiety, and blood pressure control. J Altern Complement Med. 2012;18:589–96.

20. Brook RD, Appel LJ, Rubenfire M, et al. American Heart Association Professional Education Committee of the Council for High Blood Pressure Research, Council on Cardiovascular and Stroke Nursing, Council on Epidemiology and Prevention, and Council on Nutrition, Physical Activity. Beyond medications and diet: Alternative approaches to lowering blood pressure: A scientific statement from the American Heart Association. Hypertension. 2013;61:1360–83.

21. Jain S, Uppal A, Bhatnagar S, et al. A study of response pattern of non-insulin dependent diabetics to yoga therapy. Diabetes Res Clin Pract. 1993;19:69–74.

22. Singh S, Malhotra V, Singh KP, et al. Role of yoga in modifying certain cardiovascular functions in type 2 diabetic patients. J Assoc Phys India. 2004;52:203–6.

23. Malhotra V, Singh S, Tandon OP, et al. The beneficial effects of yoga in diabetes. Nepal Med Coll J. 2005;7:145–7.

24. Kosuri M, Sridhar GR. Yoga practice in diabetes improves physical and psychological outcomes. Metab Syndr Relat Disord. 2009;7:515–7.

25. Khatri D, Mathur KC, Gahlot S, et al. Effects of yoga and meditation on clinical and biochemical parameters of metabolic syndrome. Diabetes Res Clin Pract. 2007;78:e9–e10.

26. Cohen BE, Chang AA, Grady D, et al. Restorative yoga in adults with metabolic syndrome: a randomized, controlled pilot trial. Metab Syndr Relat Disord. 2008;6:223–9.

27. Innes KE, Bourguignon C, Taylor AG. Risk indices associated with the insulin resistance syndrome, cardiovascular disease, and possible protection with yoga: a systematic review. J Am Board Fam Pract. 2005;18:491–519.

28. Paul-Labrador M, Polk D, Dwyer JH, et al. Effects of a randomized controlled trial of transcendental meditation on components of the metabolic syndrome in subjects with coronary heart disease. Arch Intern Med. 2006;166:1218–24.

29. Manchanda SC, Mehrotra UC, Makhija A, et al. Reversal of early atherosclerosis in metabolic syndrome by yoga: A randomized controlled trial. J Yoga Phys Ther. 2013;3:132.

Manchanda S Yoga as a lifestyle polypill

Page 6: Yoga as a lifestyle polypill

887886 J. Preventive Cardiology Vol. 5 No. 3 Feb 2016J. Preventive Cardiology Vol. 5 No. 3 Feb 2016

30. Mahajan A, Reddy K, Sachdeva U. Lipid profile of coronary risk subjects following yogic lifestyle intervention. Indian Heart J. 1999;51:37–40.

31. Joseph S, Sridharan K, Patil S, et al. Study of some physiological and biochemical parameters in subjects undergoing yogic training. Indian J Med Res. 1981;74:120–4.

32. Patel C. Reduction of serum cholesterol and blood pressure in hypertensive patients by behaviour modification. J Roy Coll Gen Pract. 1976;26:211–5.

33. Naruka J, Mathur R, Mathur A. Effect of pranayamas practices on fasting blood glucose and serum cholesterol. Indian J Med Sci. 1986;40:149–52.

34. Mandape A, Bharshankar J, Phatak M. Effect of raja yoga meditation on the lipid profile of healthy adults in Central India. J Med Sci Health. 2015;1:10–3.

35. Shantakumari N, Sequeira S, El Deeb R. Effects of a yoga intervention on lipid profiles of diabetes patients with dyslipidemia. Indian Heart J. 2013;65:127–31.

36. Jatuporn S, Sangwatanaroj S, Saengsiri AO, et al. Short-term effects of an intensive lifestyle modification program on lipid peroxidation and antioxidant systems in patients with coronary artery disease. Clin Hemorheol Microcirc. 2003;29:429–36.

37. Bock BC, Fava JL, Gaskins R, et al. Yoga as a complementary treatment for smoking cessation in women. J Womens Health (Larchmt). 2012;21:240–8.

38. Kochupillai V, Kumar P, Singh D, et al. Effect of rhythmic breathing (Sudarshan Kriya and Pranayam) on immune functions and tobacco addiction. Ann N Y Acad Sci. 2005;1056:242–52.

39. Tang YY, Tang R, Posner MI. Brief meditation training induces smoking reduction. Proc Natl Acad Sci USA. 2013; 110(34): 13971–5.

40. Carim-Todd L, Mitchell SH, Oken BS. Mind-body practices: an alternative, drug-free treatment for smoking cessation? A systematic review of the literature. Drug Alcohol Depend. 2013;132:399–410.

41. Dai CL, Sharma M. Between inhale and exhale: Yoga as an intervention in smoking cessation. J Evid Based Complementary Altern Med. 2014;19,144–9.

42. Chohan IS, Nayar HS, Thomas P, et al. Influence of yoga on blood coagulation. Thromb Hemost. 1984;51:196–7.

43. Schmidt T, Wijga A, Von Zur Mu¨hlen A, et al. Changes in cardiovascular r isk factors and hormones during a comprehensive residential three month kriya yoga training and v e g e t a r i a n n u t r i t i o n . A c t a P h y s i o l S c a n d S u p p l . 1997;640:158–62.

44. Singh S, Malhotra V, Singh K, et al. A preliminary report on the role of yoga asanas on oxi-dative stress in noninsulin dependent diabetes. Indian J Clin Biochem. 2001;16:216–20.

45. Bhattacharya S, Pandey U, Verma N. Improvement in oxidative status with yogic breathing in young healthy males. Indian J Physiol Pharmacol. 2002;46:349–54.

46. Sharma H, Sen S, Singh A, et al. Sudarshan kriya practitioners exhibit better antioxidant status and lower blood lactate levels. Biol Psychol. 2003;63:281–91.

47. Sinha S, Singh SN, Monga YP, et al. Improvement of glutathione and total antioxidant status with yoga. J Altern Complement Med. 2007;13:1085–90.

48. Sarvottam K, Magan D, Yadav RK, et al. Adiponectin, interleukin-6, and cardiovascular disease risk factors are modified by a short-term yoga-based lifestyle intervention in overweight and obese men. J Altern Complement Med. 2013;19:397–402.

49. Sharma M, Manchanda SC. Psychosocial risk factors and heart disease. J Prev Cardiol. 2011;1:57–65.

50. Lichtman JH, Froelicher ES, Blumenthal JA, et al. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: A scientific statement from the American Heart Association. Circulation. 2014;129:1350–69.

51. Mezzacappa ES, Kelsey RM, Katkin ES, et al. Vagal rebound and recovery from psychological stress. Psychosom Med. 2001;63:650–7.

52. Kirkwood G, Rampes H, Tuffrey V, et al. Yoga for anxiety: A systematic review of the research evidence. Br J Sports Med. 2005;39:884–91.

53. Pilkington K, Kirkwood G, Rampes H, et al. Yoga for depression: The research evidence. J Affect Disord. 2005;89:13–24.

54. Shapiro D, Cook IA, Davdov DM, et al. Yoga as a complementary treatment of depression: Effects of traits and moods on treatment ou tcome. Ev id Based Complement Al te rna t Med . 2007;4:493–502.

55. Naveen GH, Thirthalli J, Rao MG, et al. Positive therapeutic and neurotropic effects of yoga in depression: A comparative study. Indian J Psychiatry. 2013;55:S400–4.

56. Manchanda S, Narang R, Reddy K, et al. Retardation of coronary atherosclerosis with yoga lifestyle intervention. J Assoc Phys India. 2000;48:687–94.

57. Udupa KN, Singh RH. The scientific basis of yoga. JAMA. 1972;220:1365.

58. Damodaran A, Malathi A, Patil N, et al. Therapeutic potential of yoga practices in modifying cardiovascular risk profile in middle aged men and women. J Assoc Phys India. 2002;50:633–40.

59. Fields JZ, Walton KG, Schneider RH, et al. Effect of a multimodality natural medicine program on carotid atherosclerosis in older subjects: A pilot trial of Maharishi Vedic Medicine. Am J Cardiol. 2002;89:952–8.

60. Ornish D, Brown SE, Scherwitz LW, et al. Can lifestyle changes reverse coronary heart disease? The lifestyle heart trial. Lancet. 1990;336:129–33.

61. Gupta SK, Sawhney RC, Rai L, et al. Regression of coronary atherosclerosis through healthy lifestyle in coronary artery disease patients–Mount Abu open heart trial. Indian Heart J. 2011;63:461–9.

62. Yogendra J, Yogendra HJ, Ambardekar S, et al. Beneficial effects of yoga lifestyle on reversibility of ischaemic heart disease: caring heart project of International Board of Yoga. J Assoc Physicians India. 2004;52,283–9.

63. Telles S, Naveen KV. Yoga for rehabilitation: An overview. Indian J Med Sci. 1997;51:123–7.

64. Raju PS, Madhavi S, Prasad KV, et al. Comparison of effects of yoga and physical exercise in athletes. Indian J Med Res. 1994;100:81–6.

65. Malathi A, Damodaran A, Shah N, et al. Effect of yogic practices on subjective well being. Indian J Physiol Pharmacol. 2000;44:202–6.

66. Tulpule TH, Tulpule AT. Yoga – A method of relaxation for rehabilitation after myocardial infarction. Indian Heart J. 1980;32:1–7.

67. Raghuram N, Parachuri VR, Swarnagowri MV, et al. Yoga based cardiac rehabilitation after coronary artery bypass surgery: One- year results on LVEF, lipid profile and psychological states–A randomized controlled study. Indian Heart J. 2014;66:490–502.

68. Silberman A, Banthia R, Estay IS, et al. The effectiveness and efficacy of an intensive cardiac rehabilitation program in 24 sites. Am J Health Promot. 2010;24:260–6.

69. Schneider RH, Grim CE, Rainforth MV, et al. Stress reduction in the secondary prevention of cardiovascular disease: Randomized, controlled trial of transcendental meditation and health education in Blacks. Circ Cardiovasc Qual Outcomes. 2012;5:750–8.

70. Lakkireddy D, Atkins D, Pillarisetti J, et al. Effect of yoga on arrhythmia burden, anxiety, depression, and quality of life in paroxysmal atrial fibrillation: the YOGA My Heart Study. J Am Coll Cardiol. 2013;61:1177–82.

71. Ravindra PN, Madanmohan, Pavithran P. Effect of pranayam (yoga breathing) and shavasan (relaxation training) on the frequency of benign ventricular ectopics in two patients with palpitations. Int J Cardiol. 2006;108:124–5.

72. Gomes-Neto M, Rodrigues-Jr ES, Silva-Jr WM, et al. Effects of yoga in patients with chronic heart failure: A meta-analysis. Arq Bras Cardiol. 2014;103:433–9.

73. Streeter CC, Gerbag PL, Saper RB, et al. Effects of yoga on the autonomic nervous system, gamma-aminobutyric-acid, and allostasis in epilepsy, depression, and post-traumatic stress disorder. Med Hypotheses. 2012;78,571–9.

74. Feola M, Garnero S, Vallauri P, et al. Relationship between cognitive function, depression/anxiety and functional parameters in patients admitted for congestive heart failure. Open Cardiovasc Med J. 2013;7:54–60.

75. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry. 1998;55:580–92.

76. La Forge R. Mind–body fitness: Encouraging prospects for primary and secondary prevention. J Cardiovasc Nurs. 1997;11:53–65.

77. Manchanda SC. Yoga–a promising technique to control cardiovascular disease. Indian Heart J. 2014;66:487–9.

Address for correspondence:

Dr. Subhash ManchandaEmail ID: [email protected]

Manchanda S Yoga as a lifestyle polypill

Page 7: Yoga as a lifestyle polypill

887886 J. Preventive Cardiology Vol. 5 No. 3 Feb 2016J. Preventive Cardiology Vol. 5 No. 3 Feb 2016

30. Mahajan A, Reddy K, Sachdeva U. Lipid profile of coronary risk subjects following yogic lifestyle intervention. Indian Heart J. 1999;51:37–40.

31. Joseph S, Sridharan K, Patil S, et al. Study of some physiological and biochemical parameters in subjects undergoing yogic training. Indian J Med Res. 1981;74:120–4.

32. Patel C. Reduction of serum cholesterol and blood pressure in hypertensive patients by behaviour modification. J Roy Coll Gen Pract. 1976;26:211–5.

33. Naruka J, Mathur R, Mathur A. Effect of pranayamas practices on fasting blood glucose and serum cholesterol. Indian J Med Sci. 1986;40:149–52.

34. Mandape A, Bharshankar J, Phatak M. Effect of raja yoga meditation on the lipid profile of healthy adults in Central India. J Med Sci Health. 2015;1:10–3.

35. Shantakumari N, Sequeira S, El Deeb R. Effects of a yoga intervention on lipid profiles of diabetes patients with dyslipidemia. Indian Heart J. 2013;65:127–31.

36. Jatuporn S, Sangwatanaroj S, Saengsiri AO, et al. Short-term effects of an intensive lifestyle modification program on lipid peroxidation and antioxidant systems in patients with coronary artery disease. Clin Hemorheol Microcirc. 2003;29:429–36.

37. Bock BC, Fava JL, Gaskins R, et al. Yoga as a complementary treatment for smoking cessation in women. J Womens Health (Larchmt). 2012;21:240–8.

38. Kochupillai V, Kumar P, Singh D, et al. Effect of rhythmic breathing (Sudarshan Kriya and Pranayam) on immune functions and tobacco addiction. Ann N Y Acad Sci. 2005;1056:242–52.

39. Tang YY, Tang R, Posner MI. Brief meditation training induces smoking reduction. Proc Natl Acad Sci USA. 2013; 110(34): 13971–5.

40. Carim-Todd L, Mitchell SH, Oken BS. Mind-body practices: an alternative, drug-free treatment for smoking cessation? A systematic review of the literature. Drug Alcohol Depend. 2013;132:399–410.

41. Dai CL, Sharma M. Between inhale and exhale: Yoga as an intervention in smoking cessation. J Evid Based Complementary Altern Med. 2014;19,144–9.

42. Chohan IS, Nayar HS, Thomas P, et al. Influence of yoga on blood coagulation. Thromb Hemost. 1984;51:196–7.

43. Schmidt T, Wijga A, Von Zur Mu¨hlen A, et al. Changes in cardiovascular r isk factors and hormones during a comprehensive residential three month kriya yoga training and v e g e t a r i a n n u t r i t i o n . A c t a P h y s i o l S c a n d S u p p l . 1997;640:158–62.

44. Singh S, Malhotra V, Singh K, et al. A preliminary report on the role of yoga asanas on oxi-dative stress in noninsulin dependent diabetes. Indian J Clin Biochem. 2001;16:216–20.

45. Bhattacharya S, Pandey U, Verma N. Improvement in oxidative status with yogic breathing in young healthy males. Indian J Physiol Pharmacol. 2002;46:349–54.

46. Sharma H, Sen S, Singh A, et al. Sudarshan kriya practitioners exhibit better antioxidant status and lower blood lactate levels. Biol Psychol. 2003;63:281–91.

47. Sinha S, Singh SN, Monga YP, et al. Improvement of glutathione and total antioxidant status with yoga. J Altern Complement Med. 2007;13:1085–90.

48. Sarvottam K, Magan D, Yadav RK, et al. Adiponectin, interleukin-6, and cardiovascular disease risk factors are modified by a short-term yoga-based lifestyle intervention in overweight and obese men. J Altern Complement Med. 2013;19:397–402.

49. Sharma M, Manchanda SC. Psychosocial risk factors and heart disease. J Prev Cardiol. 2011;1:57–65.

50. Lichtman JH, Froelicher ES, Blumenthal JA, et al. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: A scientific statement from the American Heart Association. Circulation. 2014;129:1350–69.

51. Mezzacappa ES, Kelsey RM, Katkin ES, et al. Vagal rebound and recovery from psychological stress. Psychosom Med. 2001;63:650–7.

52. Kirkwood G, Rampes H, Tuffrey V, et al. Yoga for anxiety: A systematic review of the research evidence. Br J Sports Med. 2005;39:884–91.

53. Pilkington K, Kirkwood G, Rampes H, et al. Yoga for depression: The research evidence. J Affect Disord. 2005;89:13–24.

54. Shapiro D, Cook IA, Davdov DM, et al. Yoga as a complementary treatment of depression: Effects of traits and moods on treatment ou tcome. Ev id Based Complement Al te rna t Med . 2007;4:493–502.

55. Naveen GH, Thirthalli J, Rao MG, et al. Positive therapeutic and neurotropic effects of yoga in depression: A comparative study. Indian J Psychiatry. 2013;55:S400–4.

56. Manchanda S, Narang R, Reddy K, et al. Retardation of coronary atherosclerosis with yoga lifestyle intervention. J Assoc Phys India. 2000;48:687–94.

57. Udupa KN, Singh RH. The scientific basis of yoga. JAMA. 1972;220:1365.

58. Damodaran A, Malathi A, Patil N, et al. Therapeutic potential of yoga practices in modifying cardiovascular risk profile in middle aged men and women. J Assoc Phys India. 2002;50:633–40.

59. Fields JZ, Walton KG, Schneider RH, et al. Effect of a multimodality natural medicine program on carotid atherosclerosis in older subjects: A pilot trial of Maharishi Vedic Medicine. Am J Cardiol. 2002;89:952–8.

60. Ornish D, Brown SE, Scherwitz LW, et al. Can lifestyle changes reverse coronary heart disease? The lifestyle heart trial. Lancet. 1990;336:129–33.

61. Gupta SK, Sawhney RC, Rai L, et al. Regression of coronary atherosclerosis through healthy lifestyle in coronary artery disease patients–Mount Abu open heart trial. Indian Heart J. 2011;63:461–9.

62. Yogendra J, Yogendra HJ, Ambardekar S, et al. Beneficial effects of yoga lifestyle on reversibility of ischaemic heart disease: caring heart project of International Board of Yoga. J Assoc Physicians India. 2004;52,283–9.

63. Telles S, Naveen KV. Yoga for rehabilitation: An overview. Indian J Med Sci. 1997;51:123–7.

64. Raju PS, Madhavi S, Prasad KV, et al. Comparison of effects of yoga and physical exercise in athletes. Indian J Med Res. 1994;100:81–6.

65. Malathi A, Damodaran A, Shah N, et al. Effect of yogic practices on subjective well being. Indian J Physiol Pharmacol. 2000;44:202–6.

66. Tulpule TH, Tulpule AT. Yoga – A method of relaxation for rehabilitation after myocardial infarction. Indian Heart J. 1980;32:1–7.

67. Raghuram N, Parachuri VR, Swarnagowri MV, et al. Yoga based cardiac rehabilitation after coronary artery bypass surgery: One- year results on LVEF, lipid profile and psychological states–A randomized controlled study. Indian Heart J. 2014;66:490–502.

68. Silberman A, Banthia R, Estay IS, et al. The effectiveness and efficacy of an intensive cardiac rehabilitation program in 24 sites. Am J Health Promot. 2010;24:260–6.

69. Schneider RH, Grim CE, Rainforth MV, et al. Stress reduction in the secondary prevention of cardiovascular disease: Randomized, controlled trial of transcendental meditation and health education in Blacks. Circ Cardiovasc Qual Outcomes. 2012;5:750–8.

70. Lakkireddy D, Atkins D, Pillarisetti J, et al. Effect of yoga on arrhythmia burden, anxiety, depression, and quality of life in paroxysmal atrial fibrillation: the YOGA My Heart Study. J Am Coll Cardiol. 2013;61:1177–82.

71. Ravindra PN, Madanmohan, Pavithran P. Effect of pranayam (yoga breathing) and shavasan (relaxation training) on the frequency of benign ventricular ectopics in two patients with palpitations. Int J Cardiol. 2006;108:124–5.

72. Gomes-Neto M, Rodrigues-Jr ES, Silva-Jr WM, et al. Effects of yoga in patients with chronic heart failure: A meta-analysis. Arq Bras Cardiol. 2014;103:433–9.

73. Streeter CC, Gerbag PL, Saper RB, et al. Effects of yoga on the autonomic nervous system, gamma-aminobutyric-acid, and allostasis in epilepsy, depression, and post-traumatic stress disorder. Med Hypotheses. 2012;78,571–9.

74. Feola M, Garnero S, Vallauri P, et al. Relationship between cognitive function, depression/anxiety and functional parameters in patients admitted for congestive heart failure. Open Cardiovasc Med J. 2013;7:54–60.

75. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry. 1998;55:580–92.

76. La Forge R. Mind–body fitness: Encouraging prospects for primary and secondary prevention. J Cardiovasc Nurs. 1997;11:53–65.

77. Manchanda SC. Yoga–a promising technique to control cardiovascular disease. Indian Heart J. 2014;66:487–9.

Address for correspondence:

Dr. Subhash ManchandaEmail ID: [email protected]

Manchanda S Yoga as a lifestyle polypill